German Pharmaceuticals & Biotech Big Green Snowflakes

Merck KGaA

Market Cap: €47.0b

Operates as a science and technology company in Germany.

Cantourage Group

Market Cap: €42.3m

Operates as a medical cannabis company in Europe.

Dermapharm Holding

Market Cap: €1.7b

Manufactures and sells off-patent branded pharmaceutical products in Germany, France, Spain, Austria, Switzerland, and internationally.

SCHOTT Pharma KGaA

Market Cap: €3.3b

Develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharmaceutical, biotechnology, and life science industries worldwide.

2invest

Market Cap: €74.4m

An investment company, acquires, holds, manages, and sells investments in corporations and partnerships primarily in the biotechnology, life science, and IT sectors in Germany and internationally.

Apontis Pharma

Market Cap: €91.2m

Engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany.

Evotec

Market Cap: €1.1b

Operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally.

MPH Health Care

Market Cap: €80.3m

An investment company, engages in the healthcare business in Germany.

Darwin

Market Cap: €96.0m

Operates as a biotechnology company.

PharmaSGP Holding

Market Cap: €352.3m

Manufactures and sells over-the-counter drugs and other healthcare products in Germany.

Gerresheimer

Market Cap: €1.3b

Provides medicine packaging, drug delivery devices, and solutions in Germany and internationally.

Genetic Analysis

Market Cap: €56.7m

A science-based diagnostic company, develops diagnostic solutions for human microbiome market in the United States, Europe, and internationally.

Heidelberg Pharma

Market Cap: €160.8m

A biopharmaceutical company, focuses on oncology and antibody targeted amanitin conjugates (ATAC) in Germany, the United States, and internationally.

Respiratorius

Market Cap: €19.9m

A research company, develops drug candidates for the treatment of cancer, chronic obstructive pulmonary disease (COPD), and asthma.

Medigene

Market Cap: €985.6k

A biotechnology company, focuses on the discovery and development of T-cell therapies for the treatment of cancer.

Formycon

Market Cap: €411.6m

A biotechnology company, develops biosimilar drugs in Germany and Switzerland.

PExA

Market Cap: €9.6m

Develops and commercializes diagnostic products in various respiratory diseases.

Biomark Diagnostics

Market Cap: €19.0m

Develops early-stage cancer diagnostic technology platform to detect and treat cancer.

Bayer

Market Cap: €27.1b

Operates as a life science company worldwide.

AcuCort

Market Cap: €129.4m

Develops and commercializes glucocorticoid dexamethasone films for the treatment of acute allergic conditions.

bioXXmed

Market Cap: €135.9k

An investment company, invests in biotechnology or medical technology companies with equity or debt capital.

TFF Pharmaceuticals

Market Cap: €9.7m

A clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia.

Biofrontera

Market Cap: €16.7m

A biopharmaceutical company, engages in the research, development, and distribution of dermatological products in Germany, Spain, the United Kingdom, rest of Europe, the United States, and internationally.

Cannovum Cannabis

Market Cap: €808.9k

Engages in the manufacturing, wholesaling, and importing of medical cannabis products in Berlin.

SynBiotic

Market Cap: €19.9m

Engages in the research and development, production, and marketing of cannabinoid and terpene-based solutions to for pain, sleep deprivation, and anxiety.

PEPTONIC medical

Market Cap: €560.2m

A pharmaceutical company, researches, develops, and sells medical treatments and lifestyle products in the field of women's health.

Dextech Medical

Market Cap: €163.6m

Engages in the development of drug candidates with application in urological oncology, primarily prostate cancer.

Hamlet BioPharma

Market Cap: €941.7m

Engages in the development of drugs for the treatment and prevention of cancer in Sweden.

Sangui Biotech International

Market Cap: €419.8k

Through its subsidiaries, engages in the manufacturing and sales of wound treatment and cosmetic products.

Liminal BioSciences

Market Cap: €11.8m

Liminal BioSciences Inc., a development stage biopharmaceutical company, focuses on the development of novel small molecule drug therapeutics for inflammatory, fibrotic, and metabolic diseases in Canada and the United Kingdom.

Epigenomics

Market Cap: €780.5k

Does not have significant operations.

4SC

Market Cap: €8.8m

A biopharmaceutical company, engages in developing small-molecule drugs that address cancer diseases with high unmet medical needs in Germany and internationally.

Paion

Market Cap: €71.3k

A specialty pharmaceutical company, develops and commercializes drugs for hospital-based sedation, anesthesia, and intensive care medicine services worldwide.

Vitruvia Medical

Market Cap: €2.3m

A technology company, operates in the healthcare sector.

INDVR Brands

Market Cap: €314.1k

Provides personnel and management resources, and infrastructure and equipment for use in production, cultivation, and dispensary operations of licensed cannabis businesses in the United States.

co.don

Market Cap: €775.0k

Does not have significant operations.